Aquaporin 5 expression increases mucin production in lung adenocarcinoma

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1645-1650

  Zhang, Zi Qiang ^a   Zhu, Zhu Xian ^a   Bai, Chun Xue ^b   Chen, Zhi Hong ^b  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Aquaporin 5; Epidermal growth factor receptor (EGFR); Lung adenocarcinoma; Metastasis; Mucin

Indexed keywords

AQUAPORIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 5AC; MUCIN 5B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; AQUAPORIN 5; BLOTTING, WESTERN; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MUCIN 5AC; MUCIN-5B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 79954461502     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1241     Document Type: Article

References (32)

1. Bai C, Fukuda N, Song Y, Ma T, Matthay MA and Verkman AS: Lung fluid transport in aquaporin-1 and aquaporin-4 knockout mice. J Clin Invest 103: 555-561, 1999. (Pubitemid 29094056)
2. Verkman AS, Matthay MA and Song Y: Aquaporin water channels and lung physiology. Am J Physiol Lung Cell Mol Physiol 278: L867-L879, 2000. (Pubitemid 30351041)
3. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P and Verkman AS: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-163, 2000. (Pubitemid 30082359)
4. Papadopoulos MC, Manley GT, Krishna S and Verkman AS: Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18: 1291-1293, 2004. (Pubitemid 39561580)
5. Chae YK, Woo J, Kim MJ, Kang SK, Kim MS, Lee J, Lee SK, Gong G, Kim YH, Soria JC, Jang SJ, Sidransky D and Moon C: Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer. PLoS One 3: e2162, 2008.
6. Zhang Z, Chen Z, Song Y, Zhang P, Hu J and Bai C: Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer. J Pathol 221: 210-220, 2010.
7. Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M and Tsutani Y: Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes. Oncol Rep 15: 1157-1161, 2006.
8. Lee OJ, Kim HJ, Kim JR and Watanabe H: The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications. Oncol Rep 21: 387-393, 2009.
9. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132: 817-823, 2006. (Pubitemid 44521458)
10. Sylvester PA, Myerscough N, Warren BF, Carlstedt I, Corfield AP, Durdey P and Thomas MG: Differential expression of the chromosome 11 mucin genes in colorectal cancer. J Pathol 195: 327-335, 2001.
11. Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG and McGuckin MA: Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol 183: 311-317, 1997. (Pubitemid 27505217)
12. Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C and Flejou JF: Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol 197: 632-637, 2002.
13. You JF, Hsieh LL, Changchien CR, Chen JS, Chen JR, Chiang JM, Yeh CY, Hsieh PS, Fan CW, Liu CT and Tang R: Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin Cancer Res 12: 4244-4250, 2006.
14. Yu CJ, Yang PC, Shun CT, Lee YC, Kuo SH and Luh KT: Overexpression of MUC5 genes is associated with early postoperative metastasis in non-small-cell lung cancer. Int J Cancer 69: 457-465, 1996.
15. Kitazaki T, Soda H, Doi S, Nakano H, Nakamura Y and Kohno S: Gefitinib inhibits MUC5AC synthesis in mucin-secretirg non-small cell lung cancer cells. Lung Cancer 50: 19-24, 2005. (Pubitemid 41297465)
16. Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A and Yang PC: Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer. Lung Cancer 47: 59-67, 2005. (Pubitemid 39643242)
17. Sonora C, Mazal D, Berois N, Buisine MP, Ubillos L, Varangot M, Barrios E, Carzoglio J, Aubert JP and Osinaga E: Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues. J Histochem Cytochem 54: 289-299, 2006. (Pubitemid 43291273)
18. Chen Z, Wang X, Gao L, Bai L, Zhu R and Bai C: Regulation of MUC5AC mucin secretion by depletion of AQP5 in SPC-A1 cells. Biochem Biophys Res Commun 342: 775-781, 2006. (Pubitemid 43320466)
19. Shen Y, Chen Z, Wang Y, Song Z, Zhang Z, Jin M, Wang X and Bai C: Aquaporin 5 expression inhibited by LPS via p38/JNK signaling pathways in SPC-A1 cells. Respir Physiol Neurobiol 171: 212-217, 2010.
20. Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E and Nesland JM: EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol 196: 17-25, 2002.
21. Angulo B, Suarez- Gauthier A, Lopez-Rios F, Medina PP, Conde E, Tang M, Soler G, Lopez-Encuentra A, Cigudosa JC and Sanchez-Cespedes M: Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification. J Pathol 214: 347-356, 2008. (Pubitemid 351212390)
22. Rogers SJ, Box C, Chambers P, Barbachano Y, Nutting CM, Rhys-Evans P, Workman P, Harrington KJ and Eccles SA: Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J Pathol 218: 122-130, 2009.
23. Barton CM, Hall PA, Hughes CM, Gullick WJ and Lemoine NR: Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163: 111-116, 1991.
24. Hegab AE, Sakamoto T, Nomura A, Ishii Y, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Homma S and Sekizawa K: Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest 131: 1149-1156, 2007.
25. Hu J and Verkman AS: Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J 20: 1892-1894, 2006.
26. Barabutis N and Schally AV: Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br J Cancer 98: 1790-1796, 2008. (Pubitemid 351748851)
27. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T and Contag PR: Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20: 733-744, 2003. (Pubitemid 38019275)
28. Mitsuta K, Yokoyama A, Kondo K, Nakajima M, Arita K and Kohno N: Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis. Oncol Rep 14: 185-189, 2005.
29. Xu Y, Kimura N, Yoshida R, Lin H and Yoshinaga K: Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors. Oncol Rep 8: 1177-1182, 2001.
30. Sugihara I, Yoshida M, Shigenobu T, Takagi H, Maruyama K, Takeuchi N, Toda M, Inoue M and Nakada H: Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearirg mice. Cancer Res 66: 6175-6182, 2006.
31. Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF and Hla T: Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 101: 591-596, 2004. (Pubitemid 38084681)
32. Verkman AS: Knock-out models reveal new aquaporin functions. Handb Exp Pharmacol 190: 359-381, 2009.